Azstarys in Ora-Blend Single Dose
This new central nervous system stimulant may be used to treat attention-deficit/hyperactivity disorder in patients aged 6 years and older.
COVID-19 News Digest
Clinical developments related to coronavirus of interest to pharmacists.
New Drug Review 2021
Highlighting newly approved medications that treat attention-deficit/hyperactivity disorder, homozygous familial hypercholesterolemia, and HIV type 1 infection, and an agent for preventing pregnancy.
Managing Atopic Dermatitis in Children
The mainstay of treatment is topical agents, but more severe cases may require additional therapies.
Addressing Barriers to Emergency-Contraceptive Access
Obstacles such as state regulations, antitheft boxes, and misinformation prevent patients from obtaining emergency contraceptives in a timely manner.
Review of Selected NMEs 2021
Spotlighting new molecular entities that target COVID-19, severe hypoglycemia, metastatic non–small cell lung cancer, large B-cell lymphoma, and metastatic HER2-positive breast cancer.
Watch New
Pharmacist Recommendation Series here
Take Quiz
Continuing Education
$6.97 Per CE Exam or $59 for 12 Lessons
-
Neurology • October 2023 • 2.00 Credits
Aducanumab for the Treatment of Alzheimer’s Disease
-
• September 2023 • 2.00 Credits
Optimizing Polycystic Ovary Syndrome Outcomes
-
Pediatrics, Allergy • August 2023 • 2.00 Credits
Pediatric Food Allergy Update
Quick Poll
Copyright © 2000 - 2021 Jobson Medical Information LLC unless otherwise noted. All rights reserved. Reproduction in whole or in part without permission is prohibited.